Search Results for '24'

The Digest’s 2024 Multi-Slide Guide to Green Plains, the investment perspective

The Digest’s 2024 Multi-Slide Guide to Green Plains, the investment perspective

September 6, 2024 |

A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]

Read More

The Digest’s 2024 Multi-Slide Guide to Aemetis, the investment perspective

The Digest’s 2024 Multi-Slide Guide to Aemetis, the investment perspective

September 5, 2024 |

A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]

Read More

The Digest’s 2024 Multi-Slide Guide to Neste, the investment perspective

The Digest’s 2024 Multi-Slide Guide to Neste, the investment perspective

September 4, 2024 |

A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]

Read More

The Digest’s 2024 Multi-Slide Guide to Gevo, the investment perspective

The Digest’s 2024 Multi-Slide Guide to Gevo, the investment perspective

September 3, 2024 |

A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]

Read More

The Digest’s 2024 Multi-Slide Guide to LanzaTech, the investment perspective

The Digest’s 2024 Multi-Slide Guide to LanzaTech, the investment perspective

September 2, 2024 |

A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]

Read More

The Digest’s 2024 Multi-Slide Guide to the BOTTLE Consortium

The Digest’s 2024 Multi-Slide Guide to the BOTTLE Consortium

August 31, 2024 |

Why should DOE work on plastics circularity? For one, ~2-3% of total energy consumption in the US is used to manufacture plastics, resins, and synthetic rubber. Also, plastic production generates ~3.8% of global GHGs. Finally, plastic production uses ~6% of global oil production, representing a large opportunity for further energy and process efficiency improvements. These […]

Read More

Cepsa begins supplying cruise ships with B24 from the Port of Barcelona

Cepsa begins supplying cruise ships with B24 from the Port of Barcelona

August 29, 2024 |

In Spain, Cepsa has undertaken its first direct supply of second-generation biofuels for the cruise industry at the Port of Barcelona. Further supplies have been confirmed for the coming months, with biofuels available on a regular basis from the Ports of Barcelona and Algeciras. The supplied fuel contains a 24% sustainable component, which will prevent […]

Read More

The Digest’s 2024 Multi-Slide Guide to  Low-Pressure Hydrogenolysis Catalysts for Bioproduct Upgrading

The Digest’s 2024 Multi-Slide Guide to Low-Pressure Hydrogenolysis Catalysts for Bioproduct Upgrading

August 29, 2024 |

A team of researchers partnered with Visolis to develop a hydrogenolysis catalyst that can operate at low-pressures (≤ 5 MPa) and demonstrate conversion of a fermentation-derived C6 intermediate to a high value chemical monomer. The rewards? Risk and cost reduction for bioproduct process commercialization. And, developing a stable and selective catalyst for biomass conversion R&D. […]

Read More

OOCL switches to B24

OOCL switches to B24

August 28, 2024 |

In Hong Kong, Orient Overseas Container Line Ltd. (OOCL) and partners join hands to advance low-carbon shipping, opting for cleaner fuel to reduce supply chain emissions. With the participation of several partners including IKEA and Kyocera, the first voyage commenced in early August. The fuel used on the voyage is a B24 biofuel blend, with […]

Read More

The Digest’s 2024 Multi-Slide Guide to Catalytic Upgrading of Biochemical Intermediates

The Digest’s 2024 Multi-Slide Guide to Catalytic Upgrading of Biochemical Intermediates

August 28, 2024 |

What are the best pathways to generating and upgrading biochemical intermediates. For example, wet waste to mixed volatile fatty acids in arrested methanogenesis. Or, sugars to butyric acid, or 2,3 butanediol. Tasks include mitigation of scalability roadblocks, measurement of finished fuel properties and quantification of blend limitations, demonstration of life-cycle GHG emissions, and more. What’s […]

Read More